2-Bromothiazole-5-carboxylic acid
Based on 1 Customer Validation
2-Bromothiazole-5-carboxylic acid is a starting compound in the synthesis of active compounds. 2-Bromothiazole-5-carboxylic acid can be used in the synthesis of NAMPT/HDAC inhibitors. 2-Bromothiazole-5-carboxylic acid can be used in the research of colon cancer, lung cancer, and liver cancer.
For research use only. We do not sell to patients.
- Purity : 98.65%
- CAS No.: 54045-76-0
- Formula: C4H2BrNO2S
- Molecular Weight:208.04
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-12396
AminothiazoleVirus Protease Inhibitor -
HY-Y0045
2-AcetylthiazoleBiochemical Reagent -
HY-W001245
4-MethylthiazoleApoptosis Trigger -
HY-WAA0093
2-Amino-5-methylthiazoleBiochemical Reagent -
HY-69015
Thiazole-5-carboxyaldehydeBiochemical Reagent -
HY-W012905
5-ThiazolemethanolBiochemical Reagent -
HY-W002255
2,4-Dimethylthiazole-5-carboxylic acidBuilding Block -
HY-59320
4-Thiazolecarboxylic acidIntermediate -
HY-12396R
Aminothiazole (Standard)Virus Protease Inhibitor -
HY-WAA0093R
2-Amino-5-methylthiazole (Standard)Biochemical Reagent -
HY-W100945
2,4,5-TrimethylthiazoleBiochemical Reagent -
HY-W001223
2-BromothiazoleBiochemical Reagent
Biological Activity
Description
Chemical Information
-
CAS No. 54045-76-0
-
Appearance Solid
-
Molecular Weight 208.04
-
Formula C4H2BrNO2S
-
Color Light yellow to light brown
-
SMILES
O=C(C1=CN=C(Br)S1)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
Purity & Documentation
-
Data Sheet (266 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
2-Bromothiazole-5-carboxylic acid Related Classifications
HY-33287 Related Classifications
Powered by Bioz